Connect with us

Technology

Flow Cytometer Market to Expand by USD 8.17 Billion (2024-2028), Rising R&D Investments Drive Growth, Report on AI’s Impact on Market Trends – Technavio

Published

on

NEW YORK, Nov. 26, 2024 /PRNewswire/ — Report on how AI is redefining market landscape – The global flow cytometer market size is estimated to grow by USD 8.17 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 15.2% during the forecast period. Increasing expenditure on r and d is driving market growth, with a trend towards increasing level of process automation. However, high cost of instruments poses a challenge.Key market players include Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. And Co. KG, Shenzhen Mindray BioMedical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, On-Chip Biotechnologies Co. Ltd., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Flow Cytometer Market Scope

Report Coverage

Details

Base year

2023

Historic period

2017 – 2021

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 15.2%

Market growth 2024-2028

USD 8170.7 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

12.86

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 32%

Key countries

US, China, UK, Germany, and Canada

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. And Co. KG, Shenzhen Mindray BioMedical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, On-Chip Biotechnologies Co. Ltd., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc.

Market Driver

The Flow Cytometer Market is experiencing significant growth due to the increasing demand for multiparametric data analysis in various industries. Stem cell cultures and fluorescent-labeled antibodies are key applications driving market expansion. Flow cytometry is used extensively in the research and diagnosis of diseases such as cancer, HIV, and autoimmune disorders. FlowMetric Life Sciences, innovators in flow cytometry, provide instruments, software, and flow cytometry services for drug discovery and cell line development. Flow cytometry techniques like Western blotting, immunohistochemistry, and microscopy complement the analysis. Accessories like fluorochrome combinations, liquid handling robotics, and bead-based assays expand the capabilities of flow cytometry. The market caters to biotechnology, life science, and biopharmaceutical research activities, offering point-of-care diagnostics for tuberculosis, sexually transmitted diseases, and other infectious diseases. Digital signal processing enhances data analysis solutions, while cellular diagnostics and immunodeficiency disorders are other major applications. Flow cytometry instruments include microfluidic flow cytometry and PCR, and antibody-based testing is a significant trend. 

Flow cytometry, a laboratory technique used for analyzing and sorting cells, has seen significant advancements in automation over the past few decades. Manual sample preparation and loading have been replaced with instruments that automate these processes. These devices feature digital interfaces and store processed information, reducing the need for human intervention. Integration with other devices and processes increases flexibility, enables continuous sample flow, and decreases processing time and supervision. Modern laboratory equipment can be integrated into a digital ecosystem, ensuring a seamless transition between processes. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

Flow cytometry is a crucial technology in life sciences and biotechnology industries for analyzing cells. It allows for the measurement of multiple parameters, including the use of fluorescent-labeled antibodies and compounds, on single cells. However, handling multiparametric data can be challenging. Stem cell cultures also pose unique difficulties. Flow cytometers, instruments, accessories, and software are essential tools for this technique. In cancer, HIV, and other diseases like leukemia and lymphoma, flow cytometry plays a significant role in diagnosis and drug discovery services. Flow cytometry innovators and contract service providers offer flow cytometry analysis for immune cells, cell line development, and cellular diagnostics. Parameters like digital signal processing and fluorochrome combinations enhance the technology’s capabilities. FlowMetric Life Sciences, liquid handling robotics, and microfluidic flow cytometry are recent advancements. Applications include clinical testing labs, PCR, antibody-based testing, and point-of-care diagnostics for diseases like tuberculosis and sexually transmitted diseases.The flow cytometer market is experiencing significant growth due to the increasing demand for advanced analytical tools in drug discovery and development for infectious and chronic diseases. Flow cytometers are essential instruments in this process, offering precise and accurate data. However, the high cost of these instruments poses a challenge to market expansion. Prices range from USD100,200 to USD500,200 for a single unit, with additional expenses for reagents, markers, consumables, and accessories. This investment is justified by the valuable data generated, but it remains a significant consideration for research organizations and pharmaceutical companies.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview

This flow cytometer market report extensively covers market segmentation by

Product1.1 Reagents and consumables1.2 Instruments1.3 OthersEnd-user2.1 Pharmaceutical industry2.2 Health and diagnostic centers2.3 OthersGeography3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Reagents and consumables- The global flow cytometer market is driven by the essential role of reagents and consumables in various applications across clinical diagnostics, research, and biopharmaceutical industries. Reagents, including fluorescently labeled antibodies, viability dyes, and calibration beads, enhance cellular property detection and quantification. Innovation in reagent composition leads to more effective products for molecular and cellular biology studies. Thermo Fisher Scientific and Bio-Rad Laboratories are key vendors offering a wide range of assays, antibodies, and reagents for flow cytometry. The market growth is fueled by the increasing prevalence of chronic diseases, advancements in personalized medicine, and research activities in immunology and cancer biology. High-quality consumables ensure sample integrity and accurate flow cytometric analyses. Investments in new antibody and Deoxo-Fluor reagents will further drive demand.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Flow cytometry is a powerful analytical technique used in various fields of life science, biotechnology, and biopharmaceutical research activities. This technique enables the analysis of multiparametric data from individual cells using fluorescent-labeled antibodies or compounds. Stem cell cultures are increasingly utilizing flow cytometry for characterization and sorting. Control parameters such as forward and side scatter are used to identify and exclude debris and aggregates. Data analysis solutions help researchers make sense of the complex data generated. Flow cytometry services offer expertise and equipment for those without access to their own instruments. Flow cytometry is used in the diagnosis and research of various diseases, including autoimmune disorders, infectious diseases like HIV/AIDS, and cancer, as well as immunodeficiency disorders. Techniques such as Western blotting, immunohistochemistry, microscopy, and PCR are often used in conjunction with flow cytometry. Microfluidic flow cytometry and antibody-based testing are emerging applications. Flow cytometer instruments continue to advance, offering increased sensitivity, speed, and multiplexing capabilities.

Market Research Overview

Flow cytometry is a powerful analytical technology used to measure and analyze the physical and chemical characteristics of cells, including their size, shape, and the presence of specific markers. This technique employs the use of flow cytometers, instruments that pass single cells in suspension through a laser beam, exciting fluorescent-labeled antibodies or compounds attached to the cells. Multiparametric data is generated, allowing for the simultaneous measurement of multiple parameters. Stem cell cultures and immune cells are common applications, with flow cytometry playing a crucial role in cancer, HIV, leukemia, lymphoma, autoimmune disorders, infectious diseases, and drug discovery services. Flow cytometry analysis is essential for cell line development, immunodeficiency disorders, and biotechnology research activities. Innovations in flow cytometry include microfluidic flow cytometry, digital signal processing, point-of-care diagnostics, and cell-based flow cytometry. Accessories, software, and bead-based assays are also integral components of the flow cytometry ecosystem. FlowMetric Life Sciences and other contract service providers offer flow cytometry services to researchers and clinical testing labs. Fluorochrome combinations, liquid handling robotics, and PCR are additional tools used in conjunction with flow cytometry for various applications, including drug development activities and antibody-based testing for diseases like tuberculosis and sexually transmitted diseases.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductReagents And ConsumablesInstrumentsOthersEnd-userPharmaceutical IndustryHealth And Diagnostic CentersOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/flow-cytometer-market-to-expand-by-usd-8-17-billion-2024-2028-rising-rd-investments-drive-growth-report-on-ais-impact-on-market-trends—technavio-302315806.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CNN to bring its Global Perspectives events series to Bangkok

Published

on

By

Conversations to be led by CNN journalists including Dr. Sanjay Gupta, Richard Quest and Kristie Lu Stout

HONG KONG, April 21, 2026 /PRNewswire/ — CNN will hold the inaugural Asia chapter of its Global Perspectives events franchise in Bangkok, Thailand, on 14 October 2026, reinforcing the network’s commitment to convene global leaders and fostering dialogue on the critical issues shaping international business, policy and economic development.

CNN will bring together dignitaries, visionaries, political and business leaders for Global Perspectives: In Bangkok, to explore big ideas, bold leadership and the dynamic economies at the forefront of global transformation. On-stage conversations will be led by CNN’s esteemed anchors and correspondents, including Dr. Sanjay Gupta, Richard Quest, Kristie Lu Stout, Will Ripley and Hanako Montgomery, with editorial content and news-making interviews from the event featured across CNN platforms.

Expanding the Global Perspectives series with this Bangkok edition underscores CNN’s long-standing engagement in Asia. As a historic economic and cultural crossroads, Bangkok sits at the intersection of global economic dynamism, regional influence and vibrant cultural energy. The event will take place as global leaders, investors and policymakers gather in the city for the International Monetary Fund and World Bank Group Annual Meetings, creating an exclusive platform for CNN to examine a world in transition and the forces reshaping power and influence.

Ellana Lee, Group SVP, GM APAC, & Global Head of Productions at CNN, said: “Global Perspectives: In Bangkok will reflect CNN’s deep commitment to Asia and will aim to foster conversations that matter most on the global stage. At a time of rapid transformation, this event will bring together influential voices to examine the ideas, opportunities and challenges shaping the region and the world.” 

James Hunt, SVP, Head of Client Solutions & Business Lead, Global Perspectives, CNN International Commercial said: “Global Perspectives provides a unique platform for leaders and partners to engage in meaningful dialogue and connect with the forces driving global change. Hosting the event in Bangkok creates new opportunities for brand partners and sponsors to be associated with important conversations about collaboration, insight and impact at the heart of one of the world’s most dynamic regions.”

Expanding its events franchise by holding Global Perspectives: In Bangkok builds on CNN’s long-standing presence in Asia which includes a network of bureaus and correspondents across Hong Kong, Beijing, Bangkok, Taiwan, Seoul, Tokyo, New Delhi and Islamabad.

Global Perspectives is an invitation-only gathering for international decision-makers and influential leaders from across industries, including technology, finance, investment, trade, geopolitics, healthcare, media, entertainment and more. The event will be attended by heads of state, regional and global leaders, and participants can expect to form meaningful connections that will last well beyond the event itself. Global Perspectives will be hosted at The Ritz-Carlton, Bangkok. 

Further details on speakers and programming will be announced in due course. People interested in attending Global Perspectives: In Bangkok can register their interest at: https://cnnicevents.cnn.com/gpbangkok/prl

About CNN Worldwide

CNN Worldwide is the most honored brand in cable news, reaching more individuals through television, streaming and online than any other cable news organization in the United States. Globally, people across the world can watch CNN International, which is widely distributed in over 200 countries and territories. CNN Digital is the #1 online news destination, with more unique visitors than any other news source. HBO Max, Warner Bros. Discovery’s streaming platform, features CNN Max, a 24/7 streaming news offering available to subscribers alongside expanded access to News content and CNN Originals. CNN’s award-winning portfolio includes non-scripted programming from CNN Original Series and CNN Films for broadcast, streaming and distribution across multiple platforms. CNN programming can be found on CNN, CNN International and CNN en Español channels, via CNN Max and the CNN Originals hub on discovery+ and via pay TV subscription on CNN.com, CNN apps and cable operator platforms. Additionally, CNN Newsource is the world’s most extensively utilized news service partnering with over 1,000 local and international news organizations around the world. CNN is a division of Warner Bros. Discovery.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cnn-to-bring-its-global-perspectives-events-series-to-bangkok-302748000.html

SOURCE CNN International

Continue Reading

Technology

Quality Executive Partners, Inc.® Announces Exclusive Partnership with Vi’eNnI® Training and Consulting LLP to Accelerate Workforce Development in India’s Huge Pharmaceutical Sector with Virtuosi®

Published

on

By

ATLANTA and BENGALURU, India, April 21, 2026 /PRNewswire/ — Quality Executive Partners, Inc.® (QxP), a global leader in pharmaceutical quality, workforce development, regulatory compliance, and manufacturing consulting, today announced an exclusive strategic partnership with Vi’eNnI® Training and Consulting LLP to introduce and scale Virtuosi® across the Indian biopharmaceutical market.

Virtuosi helps biopharmaceutical manufacturers to solve one of their most critical operational challenges—the readiness of the workforce to perform in high-risk, high-complexity GMP environments—by building and sustaining operational capability across the employee lifecycle.

Under this agreement, Vienni will be QxP’s exclusive partner for Virtuosi in India, leading market engagement, client identification, and commercial activities.

Vi’eNnI® TRAINING & CONSULTING LLP: Enabling Scalable Training Excellence Across India

Vi’eNnI® is a recognized leader in pharmaceutical training and capability development in India, with a strong track record in GMP education, regulatory compliance, and industry engagement. Vi’eNnI® through its association with Eduoriens Skill Development LLP and professional bodies such as Parenteral Drug Association (PDA) India, Vienni operates at the center of India’s pharmaceutical training and compliance ecosystem.

With this established network, operational credibility, and relationships across India’s leading pharmaceutical manufacturers, Vienni is uniquely positioned to drive the adoption of Virtuosi at scale across the Indian market.

“This alliance is intended to deepen, enrich, and embed the field of training. The advantage of this collaboration is expected to make learning stick, with recall much higher when a participant leaves the learning zone,” said Vishal Sharma, Co-Founder Director, Vi’eNnI® TRAINING & CONSULTING LLP

“This marks the beginning of driving innovation and shaping outcomes that matter. Together, we forge a partnership that speaks the language of impact, influence, and enduring progress for teaching-learning & implementation,” said Ivy Louis, Founder Director, Vi’eNnI® TRAINING & CONSULTING LLP

“Vi’eNnI®’s mission is to empower doers to excel in their craft. This association with QxP for Virtuosi marks a pivotal step in advancing workforce capability and highlighting the strategic value of immersive training in India. We are proud to continue driving this mission forward.”

“We are honored to partner with Vi’eNnI® , a highly respected organization with deep roots in the Indian pharmaceutical industry,” said Crystal Mersh, Chief Executive Officer of Quality Executive Partners, Inc. “Together, we are enabling broader access to Virtuosi in a way that allows clients to build and sustain the knowledge, skills, and behaviors required to perform under real operating conditions. This embeds compliance and capability into daily execution in order to deliver high quality medicines to patients around the world.”

Virtuosi by QxP: Advancing Workforce Capability in India’s Globally Critical Pharmaceutical Hubs

India is one of the most critical pharmaceutical manufacturing markets globally and is poised for significant growth in the coming years, particularly across biologics, biosimilars, and advanced therapies. As manufacturers expand into more complex product categories and face increasing scrutiny from global regulatory agencies—including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) —the ability to rapidly build, standardize, and sustain a high-performing, inspection-ready workforce has become a strategic priority.

cGMP experts at QxP created Virtuosi to address this exact challenge. Virtuosi is an immersive workforce readiness program accredited by the International Accreditors for Continuing Education and Training (IACET), aligning with globally recognized standards for continuing education and distinguishing it as the only virtual reality–based training program to achieve such accreditation.

Combining virtual reality interactive experiences with digital course content, Virtuosi enables professionals to practice critical manufacturing and quality processes—such as aseptic operations, microbiology, and advanced therapies—in realistic, risk-free environments. The platform includes over 100 hours of education, 56 technical courses, and 20 immersive VR experiences, and is available in seven languages—English, French, German, Italian, Mandarin, Spanish, and Swedish—to support global workforce standardization. Virtuosi helps organizations reduce human error, accelerate time to competency, and improve compliance and operational performance across global pharmaceutical operations.

By shifting training from passive instruction to experiential learning, Virtuosi helps reduce time to competency and human error, improve inspection readiness, and drive measurable quality outcomes which translates directly to revenue protection and growth. This partnership strengthens not only the competitiveness of individual organizations, but also the long-term resilience, regulatory standing, and global leadership of India’s pharmaceutical sector.

About Quality Executive Partners, Inc.® (QxP)

Quality Executive Partners, Inc. (QxP) is a premium CGMP consulting firm focused on solving complex operational and regulatory challenges in pharmaceutical manufacturing. QxP services pharmaceutical manufactures and CDMOs globally across all major modalities – OTC, oral solid dosage, sterile, biologics, ATMPs, clinical-stage manufacturing, and combination products. We support clients throughout the product lifecycle, including clinical operations, commercial readiness, regulatory strategy, quality transformations, and remediation. Through our ‘Teach and Do®’ model, QxP embeds senior GMP experts / former regulators into day-to-day operations to execute alongside client teams and build internal capability. This model ensures solutions are effective in practice, sustainable, and directly reduce operational risk. .

About Vi’eNnI®

Vi’eNnI® Training and Consulting LLP is a pharmaceutical training and consulting organization based in Bengaluru, India, focused on advancing workforce capability, regulatory compliance, and operational excellence across the life sciences sector, for the past 16 years. The company delivers targeted training and consulting services across GMP, quality systems, aseptic processing, microbiology, and inspection readiness, competency and culture building initiatives, helping organizations strengthen performance, consolidate efficiency and achieve sustainable compliance. Known for its practical, implementation-focused approach, Vi’eNnI® enables pharmaceutical and biotechnology companies to translate training into measurable improvements on the shop floor, supporting continuous improvement and long-term capability development across India’s pharmaceutical industry with a variety of options and tools.

Media Contact (Global)
Robin Mersh
SVP, Virtuosi Sales
Quality Executive Partners, Inc.
Email: RobinMersh@QualityExecutivePartners.com
Phone: (+1) 678-496-7503

Media Contact (India)
Ivy Louis
Founder-Director
Vi’eNnI® Training and Consulting LLP
Email: Ivy_louis@vienni.com
Phone: +91 9986821045
WhatsApp: +91 9986821045

Vi’eNnI® & Virtuosi® are registered trademarks for VIENNI & Quality Executive Partners, Inc., respectively.

Logo – https://mma.prnewswire.com/media/2790799/5926395/Virtuosi_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/quality-executive-partners-inc-announces-exclusive-partnership-with-vienni-training-and-consulting-llp-to-accelerate-workforce-development-in-indias-huge-pharmaceutical-sector-with-virtuosi-302748013.html

Continue Reading

Technology

Tuniu Corporation Files Its Annual Report on Form 20-F

Published

on

By

NANJING, China, April 20, 2026 /PRNewswire/ — Tuniu Corporation (NASDAQ:TOUR) (“Tuniu” or the “Company”), a leading online leisure travel company in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 20, 2026, U.S. Eastern Time. The annual report can be accessed on the Company’s investor relations website at http://ir.tuniu.com or the SEC’s website at www.sec.gov. The Company will provide a copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Investor Relations Department at 12th floor, building 6-A, Juhuiyuan, No.108 Xuanwudadao, Xuanwu District, Nanjing, Jiangsu Province 210023, The People’s Republic of China.

About Tuniu Corporation

Tuniu (Nasdaq: TOUR) is a leading online leisure travel company in China that offers integrated travel service with a large selection of packaged tours, including organized and self-guided tours, as well as travel-related services for leisure travelers through its website tuniu.com and mobile platform. Tuniu provides one-stop leisure travel solutions and a compelling customer experience through its online platform and offline service network, including a dedicated team of professional customer service representatives, 24/7 call centers, extensive networks of offline retail stores and self-operated local tour operators. For more information, please visit http://ir.tuniu.com.

View original content:https://www.prnewswire.com/news-releases/tuniu-corporation-files-its-annual-report-on-form-20-f-302747995.html

SOURCE Tuniu Corporation

Continue Reading

Trending